We are live on
!
Find out more
GCM
Ghisallo Capital Management Portfolio holdings
AUM
$3.63B
1-Year Est. Return
30.51%
This Fund
S&P 500
This Quarter
Est. Return
+0.39%
1 Year Est. Return
+30.51%
3 Year Est. Return
+102.79%
5 Year Est. Return
+106.47%
10 Year Est. Return
–
AUM
$1.16B
AUM Growth
+$283M
(+32%)
Cap. Flow
+$358M
Cap. Flow
% of AUM
30.87%
Top 10 Holdings %
Top 10 Hldgs %
50.78%
Holding
151
New
50
Increased
10
Reduced
30
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CCC
CCC Intelligent Solutions
CCC
|
+$136M |
| 2 |
Digital Realty Trust
DLR
|
+$71.8M |
| 3 |
Visa
V
|
+$39.7M |
| 4 |
Birkenstock
BIRK
|
+$39.7M |
| 5 |
Kenvue
KVUE
|
+$38.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nasdaq
NDAQ
|
+$34.7M |
| 2 |
AB InBev
BUD
|
+$30.4M |
| 3 |
Haleon
HLN
|
+$25.5M |
| 4 |
TD Synnex
SNX
|
+$25.4M |
| 5 |
Bilibili
BILI
|
+$24.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.69% |
| 2 | Consumer Discretionary | 11.08% |
| 3 | Financials | 11% |
| 4 | Real Estate | 9.09% |
| 5 | Consumer Staples | 6.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Madrigal Pharmaceuticals
MDGL
$11.9B
| – | – |
-25,000
| Closed | -$6.68M |
|
|
127
Nasdaq
NDAQ
$53.9B
| – | – |
-550,000
| Closed | -$34.7M |
|
128
Blue Owl Capital
OWL
$18.3B
| – | – |
-250,000
| Closed | -$4.71M |
|
129
Procore
PCOR
$8.83B
| – | – |
-169,026
| Closed | -$13.9M |
|
|
PR
130
Permian Resources
PR
$17.5B
| – | – |
-250,000
| Closed | -$4.42M |
|
131
Patterson-UTI
PTEN
$4.12B
| – | – |
-191,978
| Closed | -$2.29M |
|
132
Sotera Health
SHC
$5.34B
| – | – |
-1,000,000
| Closed | -$12M |
|
133
SharkNinja
SN
$26B
| – | – |
-150,500
| Closed | -$9.37M |
|
|
SNCY
134
DELISTED
Sun Country Airlines
SNCY
| – | – |
-150,000
| Closed | -$2.26M |
|
|
135
TD Synnex
SNX
$20.6B
| – | – |
-225,000
| Closed | -$25.4M |
|
136
Southwest Gas
SWX
$6.57B
| – | – |
-100,000
| Closed | -$7.61M |
|
137
Metagenomi Therapeutics
MGX
$46.3M
| – | – |
-125,000
| Closed | -$1.32M |
|
138
Astera Labs
ALAB
$57B
| – | – |
-75,000
| Closed | -$5.56M |
|
|
AUGX
139
DELISTED
Augmedix, Inc. Common Stock
AUGX
| – | – |
-25,000
| Closed | -$102K |
|
Similar funds
VI
ACM
SCM
OCM
SL
AA
GCM
MTIM
Ghisallo Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, Ghisallo Capital Management held 151 positions worth $1.16B, up 32% from $877M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Ghisallo Capital Management deployed $358M of net new capital in Q2 2024, opening 50 new positions and adding to 10 existing holdings. Its largest new stake was CCC Intelligent Solutions: 11,963,771 shares worth $133M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Bilibili, an estimated $24.2M trimmed.
- Ghisallo Capital Management's largest Q2 2024 buy was CCC Intelligent Solutions: 11,963,771 shares worth $133M.
- Ghisallo Capital Management added most to Birkenstock in Q2 2024, an estimated $39.7M increase.
- Ghisallo Capital Management's biggest Q2 2024 reduction was Bilibili, cutting an estimated $24.2M.
- Ghisallo Capital Management fully exited Nasdaq in Q2 2024, selling an estimated $34.7M.
- Ghisallo Capital Management's ten largest holdings make up 51% of its $1.16B portfolio in Q2 2024.
- Ghisallo Capital Management opened 50 new positions and closed 31 in Q2 2024.
- Ghisallo Capital Management's portfolio value rose 32% quarter-over-quarter to $1.16B.
Based on Ghisallo Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.